Prostate Cancer - Results from #23820

Presence or absence of a positive pathological margin outperforms any other margin-associated variable in predicting clinically relevant biochemical recurrence in Gleason 7 prostate cancer - Abstract February 25, 2013

GU Cancers Symposium 2013 - Characterization of patients who present with de novo metastatic prostate cancer: Single-institution database analysis, by Jessica Strock, et al. - Session Highlights February 25, 2013

GU Cancers Symposium 2013 - Enzalutamide monotherapy: Phase II study results in patients with hormone-naive prostate cancer, by Bertrand Tombal, MD, PhD, et al. - Session Highlights February 25, 2013

Androgen receptor antagonists in castration-resistant prostate cancer - Abstract February 25, 2013

Benefits of a dual sagittal crystal transducer for ultrasound imaging during I-125 seed implantation for permanent prostate brachytherapy - Abstract February 25, 2013

GU Cancers Symposium 2013 - Randomized phase II trial evaluating the optimal sequencing of sipuleucel-T and androgen deprivation therapy in patients with biochemically-recurrent prostate cancer, by Emmanuel S. Antonarakis, MD, et al. - Session Highlights February 23, 2013

Potentials and limitations of real-time elastography for prostate cancer detection: A whole-mount step section analysis - Abstract February 22, 2013

Long-term tumor control after brachytherapy for base-of-prostate cancer - Abstract February 22, 2013

Progressive transition from pre-planned to intraoperative optimizing seed implant: Post implementation analysis - Abstract February 22, 2013

The role of targeted focal therapy in the management of low-risk prostate cancer: Update on current challenges - Abstract February 22, 2013

Treatment of locally advanced prostate cancer: A case report and narrative review - Abstract February 22, 2013

The changing natural history of metastatic prostate cancer - Abstract February 22, 2013

Castrate-resistant prostate cancer: Postdocetaxel management - Abstract February 22, 2013

Dynamic PET/CT measurements of induced positron activity in a prostate cancer patient after 50-MV photon radiation therapy - Abstract February 22, 2013

GU Cancers Symposium 2013 - Serum IGF-1 levels are decreased in men with advanced prostate cancer treated with the ERα agonist, GTx-758, by Evan Y. Yu, MD, et al. - Poster February 22, 2013

Prospective evaluation of a hydrogel spacer for rectal separation in dose-escalated intensity-modulated radiotherapy for clinically localized prostate cancer - Abstract February 22, 2013

Impact of bent distortion on accuracy of measurement during transrectal ultrasonography for prostatic imaging: A preliminary study - Abstract February 22, 2013

Risk of suicide in men with low-risk prostate cancer - Abstract February 22, 2013

Prostate cancer disease severity and country of origin among black men in the United States - Abstract February 22, 2013

GU Cancers Symposium 2013 - Variations in treatment modality use for the definitive management of prostate cancer in the United States, by Jay P. Ciezki, MD , et al. - Poster February 22, 2013

Page 1192 of 1438